Symptoms and treatment of systemic lupus erythematosus (SLE): The importance of early diagnosis
A group of leading physicians and specialists in rheumatology and immunology have confirmed that systemic lupus erythematosus (SLE) is one of the most prominent and complex chronic autoimmune diseases. In this disease, the immune system mistakenly attacks healthy tissues and organs, which can lead to severe inflammation affecting the skin, joints, kidneys, heart, lungs, and other vital organs. Raising awareness about this disease is crucial, especially given the ongoing medical efforts to provide the best possible healthcare for patients and protect their vital organs from damage.
Historical roots: How was lupus known throughout the ages?
To understand the nature of systemic lupus erythematosus(SLE), it is necessary to consider the historical context of its discovery. The name “lupus” comes from the Latin word for “wolf,” a term used by the physician Rogerius in the 13th century to describe skin lesions and ulcers that resembled wolf bites. As clinical medicine advanced in the 19th and 20th centuries, prominent physicians such as Moritz Capozzi and William Osler recognized that the disease was not limited to skin effects but was a systemic illness that could affect internal organs. This historical development in medical understanding paved the way for the accurate diagnoses and advanced treatments upon which modern medicine relies today.
Global and local impact of thousand-face disease
has Systemic lupus erythematosus (SLE a significant impact both locally and internationally, affecting millions of people worldwide. Statistics indicate that women comprise approximately 90% of those affected, particularly those of reproductive age. Internationally, World Lupus Day highlights the need for collaborative efforts to provide psychological support and fund scientific research. Locally and regionally, the Kingdom of Saudi Arabia has made remarkable strides in providing the latest biological treatments and immunosuppressants in its hospitals. This has alleviated the economic and psychological burden on families and enhanced the healthcare system's capacity to manage chronic diseases effectively, positively impacting the overall quality of life for the community.
Challenges of early diagnosis and the diversity of symptoms
Specialists explained to Al-Youm that the disease is known for its diverse and radically varying symptoms from patient to patient, which is why it is medically termed "the disease of a thousand faces." Symptoms may begin generally and nonspecifically, such as extreme fatigue, unexplained fever, and noticeable joint pain and swelling. This significant similarity to other autoimmune diseases makes early diagnosis a real medical challenge, requiring extensive clinical expertise, precise immunological testing, and continuous monitoring to ensure an accurate diagnosis before permanent complications develop.
Skin signs and triggers of disease activity
For her part, Dr. Hanan Mohammed Al-Rayes, a rheumatology consultant and president of the Saudi Society for Rheumatology, explained that skin symptoms are among the most common signs and may be the first indicator of early disease detection. One of the most prominent of these signs is the appearance of a red, butterfly-shaped rash on the face, extending across the cheeks and the bridge of the nose. Patients also suffer from extreme sensitivity to sunlight (ultraviolet rays), as direct exposure leads to skin irritation and increased disease activity. Other triggers for disease activity include psychological stress, chronic tension, lack of sleep, physical exertion, and abruptly stopping medication without consulting the treating physician.
Therapeutic development and the importance of psychological support
Dr. Faiza Al-Otaibi, a researcher in immunotherapy, confirmed that recent advancements have significantly contributed to improving disease control and reducing complications. She emphasized that psychological and family support plays a pivotal role in enhancing patient adherence to the treatment plan and alleviating the stress associated with the chronic nature of the disease. In a related context, Dr. Heba Yousef Al-Ajeel, a consultant dermatologist, clarified that the disease is not contagious at all. She pointed out that currently available treatments, such as corticosteroids, antimalarials, and immunosuppressants and biological agents, have contributed to reducing attacks and protecting vital organs. She concluded by stressing that community awareness and avoiding triggers are the true guarantees for achieving the best possible quality of life for patients.
